BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32588903)

  • 1. The association between adiponectin gene rs182052 polymorphism and cancer risk: a meta-analysis.
    Wu LF; Xu GP; Zhao Q; Wang D; Zhou LJ; Sun B; Chen WX
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32588903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between ATM rs1801516 polymorphism and cancer susceptibility: a meta-analysis involving 12,879 cases and 18,054 controls.
    Gu Y; Shi J; Qiu S; Qiao Y; Zhang X; Cheng Y; Liu Y
    BMC Cancer; 2018 Nov; 18(1):1060. PubMed ID: 30384829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADIPOQ polymorphism rs182052 is associated with clear cell renal cell carcinoma.
    Zhang G; Gu C; Zhu Y; Luo L; Dong D; Wan F; Zhang H; Shi G; Sun L; Ye D
    Cancer Sci; 2015 Jun; 106(6):687-691. PubMed ID: 25827778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.
    Hsueh YM; Chen WJ; Lin YC; Huang CY; Shiue HS; Yang SM; Ao PL; Pu YS; Su CT
    Toxicol Appl Pharmacol; 2018 Jul; 350():11-20. PubMed ID: 29723618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The roles of ADIPOQ rs266729 and MTNR1B rs10830963 polymorphisms in patients with gestational diabetes mellitus: A meta-analysis.
    Bai Y; Tang L; Li L; Li L
    Gene; 2020 Mar; 730():144302. PubMed ID: 31884106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adiponectin (ADIPOQ) rs2241766 G/T polymorphism is associated with risk of cancer: evidence from a meta-analysis.
    Zhou W; Liu Y; Zhong DW
    Tumour Biol; 2013 Feb; 34(1):493-504. PubMed ID: 23143890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between IGF1 Gene 3'-UTR polymorphisms and cancer risk: A Meta-analysis.
    Xu GP; Chen WX; Xie WY; Wu LF
    Medicine (Baltimore); 2018 Dec; 97(51):e13829. PubMed ID: 30572549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association Between the Polymorphism in miR-605 and Cancer Susceptibility: a PRISMA-Compliant Meta-Analysis.
    Hu M; Yu Z; Luo D; Zhang H; Li J; Liang F; Chen R
    Clin Lab; 2018 Oct; 64(11):. PubMed ID: 30549993
    [No Abstract]   [Full Text] [Related]  

  • 9. Association of adiponectin polymorphisms with the risk of diabetic nephropathy in type 2 diabetes: a meta-analysis.
    Cai Y; Zeng T; Chen L
    J Diabetes; 2015 Jan; 7(1):31-40. PubMed ID: 24825737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Associations of SNPs of the
    Smetnev S; Klimushina M; Kutsenko V; Kiseleva A; Gumanova N; Kots A; Skirko O; Ershova A; Yarovaya E; Metelskaya V; Meshkov A; Drapkina O
    Biomolecules; 2019 Sep; 9(10):. PubMed ID: 31561637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic Kidney Disease: Interaction of Adiponectin Gene Polymorphisms and Diabetes.
    Chen HH; Huang YL; Chen MC; Wu CY; Lin YC; Shiue HS; Hsu SL; Hsueh YM
    Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased cancer risk associated with the -607C/A polymorphism in interleukin-18 gene promoter: an updated meta-analysis including 12,502 subjects.
    Li X; Ren D; Li Y; Xu J; Liu C; Zhao Y
    J BUON; 2015; 20(3):902-17. PubMed ID: 26214646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interleukin-10-1082 promoter polymorphism and cancer risk: a meta-analysis.
    Wang J; Ding Q; Shi Y; Cao Q; Qin C; Zhu J; Chen J; Yin C
    Mutagenesis; 2012 May; 27(3):305-12. PubMed ID: 22058059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
    Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
    Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of the association between the CC chemokine ligand 5 (CCL5) -403 G>A gene polymorphism and tuberculosis susceptibility.
    Areeshi MY; Mandal RK; Panda AK; Haque S
    PLoS One; 2013; 8(8):e72139. PubMed ID: 24015211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between ADIPOQ +45T>G polymorphism and type 2 diabetes: a systematic review and meta-analysis.
    Fan Y; Wang K; Xu S; Chen G; Di H; Cao M; Liu C
    Int J Mol Sci; 2014 Dec; 16(1):704-23. PubMed ID: 25561226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five common haplotype-tagging variants of adiponectin (ADIPOQ) and cancer susceptibility: a meta-analysis.
    Li Q; Ma Y; Sang W; Cui W; Li X; Liu X; Zhang W
    Genet Test Mol Biomarkers; 2014 Jun; 18(6):417-24. PubMed ID: 24720830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aurora-A V57I (rs1047972) polymorphism and cancer susceptibility: a meta-analysis involving 27,269 subjects.
    Tang W; Qiu H; Jiang H; Wang L; Sun B; Gu H
    PLoS One; 2014; 9(3):e90328. PubMed ID: 24598702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of Association between miR-605 rs2043556 Polymorphism and Overall Cancer Risk: A Meta-analysis of Case-control Studies.
    Moazeni-Roodi A; Ghavami S; Hashemi M
    Microrna; 2019; 8(2):94-100. PubMed ID: 30514199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of association between leptin G-2548A polymorphisms and obesity risk: Evidence based on a meta-analysis.
    Yan J; Wang X; Tao H; Yang W; Luo M; Lin F
    Obes Res Clin Pract; 2015; 9(4):389-97. PubMed ID: 25733497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.